What Parcus Medical does

Parcus Medical is a privately held US medical device company founded in 2007 and headquartered in Sturgeon Bay, Wisconsin, with 11 to 50 employees. Per its own company description, it "develops innovative surgical product solutions that allow healthcare partners to provide patient care without compromise," operating in the surgical device space serving healthcare partners. The only source-attributable personnel record shows co-founder and president Mark Brunsvold, senior vice president Bart Bracy, and a Director of Sales Europe & Africa (Benoit D. Blancheton), pointing to a US-rooted organization that had begun building some EMEA sales reach.

The input contains extensive product, technology, financial, and competitive detail (orthopaedic implants, MySolutions/MyKnee/MySpine patient-matched platforms, NextAR digital surgical planning, FY2025 EUR-denominated revenue and EBITDA, SIX Swiss Exchange listing), but that content is explicitly attributed to Medacta International — a separately incorporated, publicly listed Swiss orthopaedic company (SIX: MTA, founded 1999, headquartered in Castel San Pietro Terme, Italy) — and is therefore not carried into Parcus Medical's profile. No source-attributed product catalog, revenue figure, customer list, pricing model, or technology stack is unambiguously Parcus Medical's. The only Parcus-attributable financial event on file is a single funding round on 2010-02-10 of $1,296,000 with unstated investors. As a result, Parcus Medical's exact product lines, revenue mechanics, customer mix, and competitive position cannot be characterized from the available source material.

Name

Parcus Medical

Legal name

Medacta International

Website

https://parcusmedical.com

Company type

Public

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Parcus Medical is a privately held US medical device company founded in 2007 in Sturgeon Bay, Wisconsin, with 11 to 50 employees. It develops surgical product solutions for healthcare partners; detailed product, financial, and technology data is not available in the input.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Orthopedic medical devices
• Surgical implant solutions
• Sports medicine products
• Minimally invasive surgery
• Joint reconstruction devices

Headquarters

HQ city

Sturgeon Bay

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device and Implant Sales: Medacta generates revenue primarily through the sale of orthopaedic implants, surgical instruments, and related medical devices for joint replacement, sports medicine, and spine surgery procedures. Revenue is derived from一次性 product sales to hospitals and surgical centers.
2. Education and Training Services: The company generates revenue through its M.O.R.E. Institute education programs, fellowship programs, and surgeon training courses. These professional education services complement product sales and drive adoption.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Parcus Medical develops innovative surgical product solutions that allow healthcare partners to provide patient care without compromise. The company operates as a small, private medical device firm focused on surgical product development for the healthcare provider market.

Product overview

Medacta offers a comprehensive orthopedic portfolio organized across Joint Reconstruction (Hip, Knee, Shoulder), Spine, and Sports Medicine segments. The Hip portfolio includes AMIS anterior approach technique with femoral systems (QUADRA-P, QUADRA, MASTERLOC, SMS, MINIMAX) and acetabular systems (VERSAFITCUP CC TRIO, VERSAFITCUP DM, MPACT). The Knee portfolio features GMK Sphere and GMK Primary total knee systems, MOTO Platform for partial knee replacement, GMK Revision and GMK Hinge for revision cases, supported by MYKNEE patient-matched technology and NEXTAR digital planning platform. The Shoulder portfolio includes Medacta Shoulder System and MYSHOULDER planning technology. Sports Medicine products include FairFix (ACL/PCL fixation), X-Twist suture anchors, Draw Tight anchors, MectaQTH quadriceps tendon harvest system, QuickStitch meniscus repair, and SnugFit all-suture anchors. The MySolutions Personalized Ecosystem provides the technological foundation across all segments, integrating preoperative planning, anatomical analysis, and procedure-specific instrumentation. NEXTAR serves as the AI-assisted digital surgery platform across knee, shoulder, and spine.

Differentiator

Problem solved

Functional benefit

Brands

• MySolutions: Personalized ecosystem platform for surgical planning and execution across orthopaedic procedures
• MyKnee
• MySpine
• AMIS
• M.O.R.E.
• NextAR
• GMK
• MOTO Platform

Quantifiable outcome

• 42.5% increase in operating cash flow year-over-year (FY 2025)
• +2 more outcomes

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators7 records

Recent moves2 records

Expansion highlights2 records

Emerging players

• Integra LifeSciences: Specialty surgical and orthopedic company with extremity and sports medicine offerings that overlap with Parcus Medical's foot/ankle and soft-tissue fixation categories.
• Anika Therapeutics: Mid-stage orthopedic and sports medicine company focused on hyaluronic acid viscosupplementation and regenerative solutions, with adjacent relevance to Parcus's sports medicine surgical niche.
• RTI Surgical: Surgical implant company with sports medicine and tendon/ligament allograft offerings, providing adjacent competition in soft-tissue sports medicine procedures where Parcus Medical operates.
• Vericel: Sports medicine-focused company with cartilage repair and MACI franchise, adjacent to Parcus Medical's procedural call points in sports orthopedic surgery.

Broad incumbents

• DePuy Synthes (Johnson & Johnson): Major orthopedic incumbent with a Mitek Sports Medicine division offering ACL/PCL reconstruction and soft-tissue fixation products overlapping Parcus Medical's procedural segments, supported by J&J's global scale.
• Smith & Nephew: Diversified medical device incumbent with a sports medicine portfolio (formerly ArthroCare/Cayenne) covering ACL/PCL fixation, meniscus repair, and shoulder arthroscopy — directly overlapping Parcus Medical's product set.
• Stryker: Large diversified device company with a sports medicine segment (post-Wright Medical acquisition) that competes in soft-tissue fixation and arthroscopy, providing scale advantages Parcus Medical cannot match standalone.
• Zimmer Biomet: Diversified orthopedic device leader with sports medicine offerings across knee, shoulder, and extremities that compete in adjacent call points to Parcus Medical's sports medicine portfolio.

Direct peers

• Arthrex: The dominant global sports medicine device company offering suture anchors, fixation devices, and ACL/PCL reconstruction products directly competing with Parcus Medical's FairFix, X-Twist, and Draw Tight anchor portfolio across the same surgeon call points.
• Conmed: Mid-sized medical device company with a focused sports medicine and orthopedic franchise offering suture anchors, meniscus repair devices, and surgical instruments that directly compete with Parcus Medical's soft-tissue fixation portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks5 records

Key highlights5 records

Customer concentration

• Xtwitter.com/medacta
• YouTubeyoutube.com/user/MedactaInternational
• LinkedInlinkedin.com/company/anika-therapeutics

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parcus Medical